In order to most rapidly
realize the value of genetics for human health, deCODE is currently partnering with life sciences
companies to accelerate their target discovery, validation, and prioritization efforts, yielding improved patient stratification for clinical trials and essential companion
diagnostics.
In addition, the
company collaborates with biopharmaceutical
companies in the development of companion
diagnostic tests and technologies for various cancer therapies, helping to
realize the promise of precision oncology.